BENITIONSClinical Trial Intelligence

Vitamin D and Physical Activity on Bone Health

2期 进行中(已停止招募) NCT01419730

适应症Bone Metabolism Biomarkers, Bone Mineral Density, Physical Fitness
分期2期
申办方University of Rochester
状态进行中(已停止招募)
受试者人数191 人
干预(药物)Vitamin D3, Physical Activity
开始日期2011年8月
完成日期2024年12月30日
结果公布日2026年8月5日

摘要

This research will examine the effectiveness of vitamin D or placebo (the placebo is a tablet that looks like Vitamin D study drug, but has no Vitamin D study drug in it), with and without physical activity (walking and progressive resistance exercise), in treating bone loss in women who have undergone treatment for breast cancer. The investigators would also like to find out if the physical activity program improves cardiovascular fitness, energy expenditure, muscular strength, muscle mass, and balance. One hundred five (105) subjects are expected to take part in this study. The investigators don't know if bone loss in breast cancer survivors should be treated differently than bone loss in other women.

Measure the Amount of Bone Mineral Density Loss in Non-metastatic Breast Cancer Patients Receiving a High Dose Vitamin D Therapy Along With a Structured Home-based Walking and Progressive Resistance Exercise Program.

24 weeks · Change in Hip BMD g/cm^2

High Dose Vitamin D-0.0015 ± 0.0045 Change in Hip BMD g/cm^2
High Dose Vitamin D + Exercise-0.0013 ± 0.0044 Change in Hip BMD g/cm^2
Control-0.0163 ± 0.0058 Change in Hip BMD g/cm^2
p-value0.064
F Statistic2.838

在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文

同一适应症的其他试验

全部试验

本页整理自 ClinicalTrials.gov 的公开数据,不构成医疗建议,也不构成投资建议。请务必咨询专业医师。